证券代码：301045 证券简称：天禄科技 公告编号：2025-034 苏州天禄光科技股份有限公司 2024 年年度股东大会会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 一、会议召开情况 1、会议召开时间 （1）现场会议召开时间：2025 年 5 月 14 日（星期三）14：30 （2）网络投票时间：2025 年 5 月 14 日 其中，通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 5 月 14 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投 票时间为 2025 年 5 月 14 日 9:15-15:00 期间的任意时间。 2、会议的召开方式：本次股东大会采取现场表决与网络投票相结合的方式。 3、股东大会的召集人：公司董事会 4、股东大会的主持人：董事长梅坦先生 1、本次股东大会无否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 3、中小股东是指除公司董事、监事、高级管理人员以及单独或合计持有公 司 5%以上股份的股东以外的其他股东。 二 ...

天禄科技 2024 年年度股东会 法律意见书 江苏世纪同仁律师事务所 关于苏州天禄光科技股份有限公司 2024 年年度股东会的法律意见书 苏州天禄光科技股份有限公司： 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司股东 会规则》等法律、法规和规范性文件以及《公司章程》的规定，本所受公司董事 会委托，指派本所律师出席公司 2024 年年度股东会，并就本次股东会的召集、 召开程序、出席会议人员资格、召集人资格、表决程序以及表决结果的合法有效 性等事项出具法律意见书。 为出具本法律意见书，本所律师对本次股东会所涉及的有关事项进行了审查， 查阅了相关会议文件，并对有关问题进行了必要的核查和验证。 本所律师同意将本法律意见书随公司本次股东会决议一并公告，并依法对本 法律意见书承担相应的责任。 本所律师根据相关法律、法规和规范性文件的要求，按照律师行业公认的业 务标准、道德规范和勤勉尽责精神，出具法律意见如下： 一、关于本次股东会的召集和召开 1、本次股东会由公司董事会召集 2025 年 4 月 11 日，公司召开了第三届董事会第二十八次会议，决定于 2025 年 5 月 14 日召开本次股东会。公司已于 ...

关于苏州天禄光科技股份有限公司 首次公开发行股票并在创业板上市持续督导保荐总结报告书 根据中国证券监督管理委员会证监许可20212058 号文批复，并经深圳证 券交易所同意，苏州天禄光科技股份有限公司（以下简称"天禄科技""发行 人"或"公司"）由主承销商中泰证券股份有限公司于 2021 年 8 月 4 日在深圳证 券交易所采取网下向符合条件的投资者询价配售和网上向持有深圳市场非限售 A 股股份或非限售存托凭证市值的社会公众投资者定价发行相结合的方式向社 会公众公开发行人民币普通股（A 股）2,579.00 万股，发行价为每股人民币 用 4,573.69 万元后，募集资金净额为 36,200.30 万元。公司首次公开发行的股票 于 2021 年 8 月 13 日上市交易。 中泰证券股份有限公司 根据中国证监会的规定，保荐机构对天禄科技首次公开发行股票项目的持 续督导期为 2021 年 8 月 13 日至 2024 年 12 月 31 日。持续督导期间，保荐机构 及保荐代表人根据中国证监会的相关规定及深圳证券交易所等监管部门的有关 要求，认真履行持续督导职责，主要保荐工作具体如下： 人、其他关联方违规占用公司资 ...

中泰证券股份有限公司 关于苏州天禄光科技股份有限公司 首次公开发行股票并在创业板上市持续督导保荐总结报告书 2、本保荐机构及本人自愿接受中国证监会对保荐总结报告书相关事项进行 的任何质询和调查。 3、本保荐机构及本人自愿接受中国证监会按照《证券发行上市保荐业务管 1 理办法》的有关规定采取的监管措施。 二、保荐机构基本情况 | 保荐机构名称 | 中泰证券股份有限公司 | | --- | --- | | 注册地址 | 山东省济南市经七路 86 号 | | 办公地址 | 山东省济南市经七路 86 号 | | 法定代表人 | 王洪 | | 保荐代表人 | 王飞、潘世海 | | 联系电话 | 0531-68889236 | | 是否更换保荐人或其他情况 | 无 | | 三、公司基本情况 | | --- | 根据中国证券监督管理委员会证监许可[2021]2058 号文批复，并经深圳证 券交易所同意，苏州天禄光科技股份有限公司（以下简称"天禄科技""发行 人"或"公司"）由主承销商中泰证券股份有限公司于 2021年 8月 4日在深圳证 券交易所采取网下向符合条件的投资者询价配售和网上向持有深圳市场非限售 A 股股份或非限 ...

Investment Rating - The report maintains a "Positive" outlook on the chemical industry, highlighting the recovery at the bottom of the cycle and the focus on undervalued high-growth stocks [1]. Core Insights - The macroeconomic assessment of the chemical industry indicates a stabilization in oil prices due to geopolitical factors and OPEC+ production increases, while coal prices are expected to decline in the medium to long term. Natural gas prices are fluctuating at the bottom [3][4]. - The report forecasts a gradual recovery in profitability for the chemical sector in Q1 2025, driven by terminal inventory replenishment and improved demand, despite ongoing construction projects peaking and declining [3]. - The overall revenue for the chemical sector in 2024 is projected to reach 2.0601 trillion yuan, a 3% year-on-year increase, while net profit is expected to decline by 3% to 109.8 billion yuan, aligning with market expectations [3]. Summary by Sections Industry Dynamics - Current oil prices are influenced by the easing of the Russia-Ukraine conflict and U.S. tariff policies, with Brent crude averaging $80.93 per barrel in 2024, down 2% year-on-year. NYMEX natural gas futures are expected to average $2.41 per million British thermal units, down 10% year-on-year [3][4]. - The chemical industry is experiencing a "V"-shaped recovery in market conditions, with Q1 2025 revenue reaching 496.9 billion yuan, a 6% increase year-on-year, and net profit rising by 9% year-on-year to 32.8 billion yuan [3]. Investment Analysis - The report suggests focusing on traditional cyclical stocks with strong fundamentals, such as Wanhua Chemical and Hualu Chemical, as well as growth stocks in semiconductor materials and OLED technologies [3]. - The tire industry is expected to benefit from domestic demand recovery and cost reductions, with companies like Sailun Tire and Linglong Tire highlighted for potential investment [3]. - The report emphasizes the importance of identifying undervalued stocks with growth potential in the chemical sector, particularly in segments like agricultural chemicals and specialty chemicals [3]. Price and Inventory Changes - The report notes that the chemical industry is experiencing a gradual recovery in price differentials, with PPI data showing a slow recovery from negative values towards zero [3][4]. - The report highlights the importance of monitoring inventory levels and price movements in key chemical products, as these factors will influence future profitability and investment opportunities [3][4].

2024年年度持续督导跟踪报告 | 保荐机构名称：中泰证券股份有限公司 | 被保荐公司简称：天禄科技 | | --- | --- | | 保荐代表人姓名：王飞 | 联系电话：0531-68889236 | | 保荐代表人姓名：潘世海 | 联系电话：0531-68889236 | | 保荐代表人姓名：关峰 | 联系电话：0531-68889236 | 中泰证券股份有限公司 关于苏州天禄光科技股份有限公司 四、其他事项 | 报告事项 | 说明 | | --- | --- | | 1.保荐代表人变更及其理由 | 无 | | 2.报告期内中国证监会和交易所对保 荐机构或者其保荐的公司采取监管措 | 无 | | 施的事项及整改情况 | | | 3.其他需要报告的重大事项 | 无 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的 | 0次 | | 次数 | | | 2.督导公司建立健全并有效执行规章制 | | | 度的情况 | | | （1）是否督导公司建立健全规章 ...

Group 1: Sales and Financial Performance - In 2024, the company achieved operating revenue of 654 million RMB, an increase of 9.67% compared to 2023 [4] - The net profit attributable to shareholders reached 27.12 million RMB, up 206.84% from 2023 [4] - The cash flow from operating activities was -16.04 million RMB in 2024, primarily due to increased procurement payments and strategic inventory buildup [3] Group 2: Product and Market Insights - The company's overseas sales amounted to 80.35 million RMB, accounting for 12.38% of total sales, with key markets including Indonesia, Poland, Taiwan, and Mexico [3] - The high-margin product, prism-type dot technology, has a gross margin of approximately 40%, contributing significantly to profitability [4] - The company plans to expand its product applications into high-value sectors such as automotive and industrial control [5] Group 3: Research and Development - In 2024, R&D expenses were 3.51 million RMB, representing a 20% increase from 2023, with R&D spending as a percentage of revenue continuing to rise [3] - The R&D team consists of 92 professionals with expertise in optics, materials science, mathematics, and automation [3] Group 4: Strategic Initiatives and Future Outlook - The company is focused on enhancing its competitive edge through continuous product innovation and maintaining strong communication with investors [4] - The TAC film project is progressing well, with equipment procurement and investor engagement underway [4] - The company has established a comprehensive quality control system and aims to maintain its reputation in the industry [4]

前十大流通股东累计持有： 2480.4万股，累计占流通股比： 36.88%，较上期变化： 53.22万股。 | 持有数量(万股) 名称 | | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 梅坦 | 709.01 | 10.54 | 179.10 | | 陈凌 | 575.80 | 8.56 | 不变 | | 马长建 | 531.58 | 7.91 | 不变 | | 北京芯动能投资管理有限公司-天津显智链投资中心 (有限合伙) | 251.68 | 3.74 | 不变 | | 马坤 | 86.59 | 1.29 | 不变 | | 苏州市相城埭溪创业投资有限责任公司 | 78.88 | 1.17 | -7.24 | | 袁喜 | 70.50 | 1.05 | 新进 | | 长城人寿保险股份有限公司-分红-个人分红 | 60.00 | 0.89 | 新进 | | 佟晓刚 | 59.10 | 0.88 | 新进 | | 黄拓宇 | 57.26 | 0.85 | 新进 | | 较上个报告期退出前十大股东有 | | | | | 乔毅臣 | ...

证券代码：301045 证券简称：天禄科技 公告编号：2025-033 一、本次计提资产减值准备情况概述 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 苏州天禄光科技股份有限公司 关于 2025 年第一季度计提资产减值准备的公告 本期计提资产减值准备的资产主要为存货；本期计提信用减值准备的资产主 要为应收账款和其他应收款。2025 年第一季度公司计提各项减值准备金额合计 -1,978,670.42 元（损失以"-"号表示），具体情况如下： | 项目 | 本期计提金额（元） | | | --- | --- | --- | | 一、信用减值损失 | | | | 应收账款坏账损失 | | 134,203.00 | | 其他应收款坏账损失 | | -83,027.99 | | 二、资产减值损失 | | | | 存货跌价损失 | | -2,029,845.43 | | 合计 | | -1,978,670.42 | 二、本次计提资产减值准备情况说明 （一）应收款项计提坏账准备 公司对在单项工具层面能以合理成本评估预期信用损失的充分证据的应收 账款单独确定其信用损失。 苏 ...

Financial Performance - The company's revenue for Q1 2025 was ¥146,040,152.69, a decrease of 3.89% compared to ¥151,949,723.21 in the same period last year[5] - Net profit attributable to shareholders increased by 6.17% to ¥5,467,975.17 from ¥5,150,126.57 year-on-year[5] - Total operating revenue for the current period was CNY 146,040,152.69, a decrease of 3.99% from CNY 151,949,723.21 in the previous period[19] - Net profit attributable to the parent company was CNY 5,467,975.17, an increase of 6.14% compared to CNY 5,150,126.57 in the previous period[20] - Total operating costs decreased to CNY 140,615,867.43, down 4.73% from CNY 147,384,282.94[19] Cash Flow - The net cash flow from operating activities surged by 5,090.02% to ¥7,431,661.71, compared to a negative cash flow of ¥148,930.44 in the previous year[5] - Cash flow from operating activities was CNY 152,673,631.04, compared to CNY 159,770,902.22 in the previous period[22] - Net cash flow from operating activities was 7,431,661.71, a significant improvement from -148,930.44 in the previous period[23] - Cash received from operating activities amounted to 160,976,782.22, slightly lower than 165,182,082.13 in the previous period[23] - Total cash outflow from operating activities was 153,545,120.51, compared to 165,331,012.57 previously[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,312,643,493.30, reflecting a decrease of 3.44% from ¥1,359,420,316.10 at the end of the previous year[5] - Total liabilities decreased to CNY 226,262,650.48, down 18.58% from CNY 277,897,354.84[18] - The total current assets decreased from ¥707,464,818.10 to ¥672,367,924.09, a reduction of about 4.9%[16] - The inventory decreased from ¥98,657,213.29 to ¥86,806,480.09, a decline of approximately 12%[16] - The total non-current assets include fixed assets valued at ¥239,214,935.02, down from ¥244,553,184.97[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,069[12] - The top 10 shareholders hold a combined 78.81% of the shares, with the largest shareholder, Meitan, owning 25.71%[12] - The company has a total of 40,602,326 restricted shares at the end of the reporting period[14] - The total number of restricted shares held by Meitan decreased from 23,061,259 to 21,270,256, with 1,791,003 shares released from restriction[14] - There are no changes in the top 10 shareholders due to margin trading activities[13] Financial Expenses and Taxes - Financial expenses decreased by 60.11% to -¥1,118,418.28, mainly due to reduced bank interest income and exchange gains[10] - The company reported a 138.79% increase in income tax expenses to ¥1,094,633.94, driven by increased profits during the period[10] - The company reported a financial expense of CNY -1,118,418.28, a significant improvement from CNY -2,803,406.24 in the previous period[19] Earnings Per Share - The company's basic and diluted earnings per share remained unchanged at ¥0.05[5] - Basic and diluted earnings per share remained stable at CNY 0.05 for both periods[20] Audit Information - The company did not conduct an audit for the first quarter report[25]